Literature DB >> 3582096

Healon as intravitreal substitute in retinal detachment surgery in 40 patients.

R Koster, J S Stilma.   

Abstract

Forty patients with hypotony during retinal detachment surgery were treated with intravitreal Healon. Healon was very well tolerated, except for a transient rise in the intra-ocular pressure in 19 out of 40 patients. A relationship between the rise in intra-ocular pressure and the mount of Healon used was not found. Temporal corneal decompensation occurred in two patients. Early cases of proliferative vitreo-retinopathy with retinal detachment were treated successfully with external retinal-detachment surgery and intravitreal Healon.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3582096     DOI: 10.1007/bf00166680

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  6 in total

1.  Massive periretinal proliferation: a logical approach to therapy.

Authors:  R Machemer
Journal:  Trans Am Ophthalmol Soc       Date:  1977

2.  Proliferative vitreoretinopathy. The Silicone Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1985-05-15       Impact factor: 5.258

3.  Comparison of the effects of Viscoat and Healon on postoperative intraocular pressure.

Authors:  B A Barron; M Busin; C Page; D R Bergsma; H E Kaufman
Journal:  Am J Ophthalmol       Date:  1985-09-15       Impact factor: 5.258

4.  [Liquid silicone in amotio surgery (II). Report on 280 cases - further development of the technic].

Authors:  R Zivojnović; D A Mertens; E Peperkamp
Journal:  Klin Monbl Augenheilkd       Date:  1982-12       Impact factor: 0.700

5.  Comparison of vitreous replacement with Healon and with HPMC in rabbits' eyes.

Authors:  R Koster; J S Stilma
Journal:  Doc Ophthalmol       Date:  1986-01-15       Impact factor: 2.379

6.  Hyaluronic acid vitreous substitute. A six-year clinical evaluation.

Authors:  R C Pruett; C L Schepens; D A Swann
Journal:  Arch Ophthalmol       Date:  1979-12
  6 in total
  5 in total

1.  Experimental vitreous tamponade using polyalkylimide hydrogel.

Authors:  Sven Crafoord; Sten Andreasson; Fredrik Ghosh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-03-31       Impact factor: 3.117

2.  Evaluation of viscoelastic poly(ethylene glycol) sols as vitreous substitutes in an experimental vitrectomy model in rabbits.

Authors:  Christopher D Pritchard; Sven Crafoord; Sten Andréasson; Karin M Arnér; Timothy M O'Shea; Robert Langer; Fredrik K Ghosh
Journal:  Acta Biomater       Date:  2010-11-24       Impact factor: 8.947

3.  A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute.

Authors:  Henrik Barth; Sven Crafoord; Sten Andréasson; Fredrik Ghosh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-08       Impact factor: 3.117

4.  A new model for in vitro testing of vitreous substitute candidates.

Authors:  Henrik Barth; Sven Crafoord; Timothy M O'Shea; Christopher D Pritchard; Robert Langer; Fredrik Ghosh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-25       Impact factor: 3.117

Review 5.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.